News & Trends - Biotechnology
Ex-AusBiotech CEO to spearhead manufacturing technology peak body
The former CEO of AusBiotech is set to lead the peak body advocating for manufacturing technology suppliers and users in the precision engineering and advanced manufacturing domain.
On May 1st, Lorraine Maxwell (Chiroiu) assumes leadership at AMTIL (Australian Manufacturing Technology Institute Limited), succeeding outgoing CEO Shane Infanti, who held the position for 25 years.
Lorraine spearheaded AusBiotech’s efforts to grow and showcase Australia’s prowess in biotechnology, shaping policy shifts with both state and Federal governments, fostering and expanding its extensive membership base of 3000, and achieving milestones through strategic alliances and collaborations.
Her pivotal contributions extend to the development and advocacy of manufacturing policies. Presently, she chairs CSIRO’s Manufacturing Business Unit Advisory Group and holds a Ministerial appointment to the Trade 2040 Taskforce, underscoring her influential role in shaping the trajectory of manufacturing and trade in Australia.
AMTIL President, Brigitte Stavar, said “We are so delighted to have secured Lorraine in this role. Her skill set is exactly what we were looking for and we are sure she will be able to take AMTIL on their next phase of evolution. This next phase includes a stronger level of advocacy and a voice for our local manufacturers. Lorraine’s expertise in this area is definitely a key reason why she was successful through the application process.”
Shane indicated he had mixed feelings about leaving AMTIL after such a long tenure. “When I was employed as CEO in 1999, I couldn’t have imagined the journey it would take me on, the friendships I would make and the impact our small organisation would have on the manufacturing sector in Australia.
“I am genuinely excited about handing over to Lorraine. Her fresh set of eyes, strategic mindset and renewed enthusiasm will take us a long way into the future.”
Lorraine congratulated Shane on his significant legacy and contribution to AMTIL, saying “It is a great privilege to join an organisation that is successful, solid and has a view to the future. I look forward to leading AMTIL with the Board to further build Australian manufacturing.”
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More